Quantcast

Latest hypoglycemia Stories

2011-09-09 07:00:00

Research has shown that a diabeticâs sweat pattern undergoes changes when blood glucose levels drop too low. Now a sweat meter developed jointly at the University of Olso in Norway and the National Hospital may be able to monitor sweat patterns to determine irregularities in blood glucose levels and send an alert via text message before the patient suffers an attack. Tampa, FL (PRWEB) September 09, 2011 Sweat Meter May Alert Diabetics to Low Blood Glucose: Type 2 diabetics...

2011-08-09 07:00:00

PHILADELPHIA, Aug. 9, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced the unveiling of a much anticipated demonstration video on the Company's website at www.echotx.com. The new video showcases the features and ease of use of the Symphony continuous glucose...

2011-08-01 14:33:51

Research published in The Cochrane Library found that the risk of death and cardiovascular disease, such as stroke, was unchanged whether glucose control was intense or conventional. They did find, however, that when aiming to keep blood glucose levels at the lower intensive level, the chance of damaging small blood vessels in the body, potentially leading to damage in the eyes and kidneys, is reduced. But aiming for this lower level with the more intensive glucose control substantially...

2011-07-27 13:34:29

Research: Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death and microvascular events in Type 2 diabetes: Meta-analysis of randomized controlled trials Doctors should be cautious about prescribing intensive glucose lowering treatment for patients with type 2 diabetes as a way of reducing heart complications, concludes a new study published on bmj.com today. French researchers found that intensive glucose lowering treatment, which is widely used for...

2011-07-27 05:00:00

CALGARY, Alberta, July 27, 2011 /PRNewswire/ -- Fero Industries, Inc. (OTCQB: FROI) (the "Company") is pleased to report that Merck S.A. de C.V. has increased its Sucanon® promotional campaign across Mexico to include physician distributed sample packages. Four tablet sample packages of Sucanon® will be provided to patients at no-cost based on the physician's discretion to raise awareness and encourage long-term customer acceptance of the product. "The...

2011-07-20 12:47:00

JDRF says Pending Artificial Pancreas Guidance is FDA's Opportunity to Turn the Tide NEW YORK, July 20, 2011 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation (JDRF) welcomed Congress's attention today to the important issue of medical device regulatory reform and reiterated the life-changing difference the FDA's pending artificial pancreas guidance will make in the lives of millions of individuals with type 1 diabetes across the country. The hearing, "FDA Medical...

2011-07-14 15:29:11

Indications of advantages but also of disadvantages / Fewer non-fatal heart attacks on the one hand, but more hypoglycaemic episodes on the other Whether patients with type 2 diabetes mellitus benefit from attempts to lower their blood glucose levels to near-normal levels through treatment ("intensive blood glucose control") remains an unanswered question. The studies currently available provide indications of a benefit but also of potential harm. This is the result of a report published by...

2011-07-08 09:42:00

WORCESTER, Mass. and TORONTO, July 8, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTC Bulletin Board: GNBT) (www.generex.com) today announced preliminary clinical results of two major trials using the Generex Oral-lyn(TM) formulation that will be used for registration and marketing. Unlike prior reported results from studies using older versions of the formulation, the combined data from the now completed 084 Trial in Type 1 patients and the Prevoral Trial in patients with...


Latest hypoglycemia Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related